


Ignacio Pino
Drug Discovery
Ignacio Pino is the co-founder and Chief Operating Officer of CDI Labs, where he has led the development of cutting-edge technology platforms such as Hu-Prot to advance pharmaceutical research and basic science discovery. Under his leadership, CDI Labs has grown into a recognized player in Puerto Rico’s biotech sector, bridging academic innovation with applications in antibodies, biomarkers, and drug discovery.
With extensive experience in biotechnology operations, Ignacio brings a unique combination of scientific expertise, strategic vision, and entrepreneurial execution. He has a proven record of translating early-stage technologies into scalable solutions that serve both industry and academia, positioning BioVergence to accelerate collaboration across ecosystems and drive meaningful impact at the intersection of science and commercialization.




Ignacio Pino
Drug Discovery
Ignacio Pino is the co-founder and Chief Operating Officer of CDI Labs, where he has led the development of cutting-edge technology platforms such as Hu-Prot to advance pharmaceutical research and basic science discovery. Under his leadership, CDI Labs has grown into a recognized player in Puerto Rico’s biotech sector, bridging academic innovation with applications in antibodies, biomarkers, and drug discovery.
With extensive experience in biotechnology operations, Ignacio brings a unique combination of scientific expertise, strategic vision, and entrepreneurial execution. He has a proven record of translating early-stage technologies into scalable solutions that serve both industry and academia, positioning BioVergence to accelerate collaboration across ecosystems and drive meaningful impact at the intersection of science and commercialization.
